↓ Skip to main content

Outcome selection for tissue-agnostic drug trials for immune-mediated inflammatory diseases: a systematic review of core outcome sets and regulatory guidance

Overview of attention for article published in Trials, January 2022
Altmetric Badge

Mentioned by

twitter
12 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Outcome selection for tissue-agnostic drug trials for immune-mediated inflammatory diseases: a systematic review of core outcome sets and regulatory guidance
Published in
Trials, January 2022
DOI 10.1186/s13063-022-06000-w
Pubmed ID
Authors

Olalekan Lee Aiyegbusi, Lavinia Ferrante di Ruffano, Ameeta Retzer, Philip N. Newsome, Christopher D. Buckley, Melanie J. Calvert

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 41 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 11 27%
Other 3 7%
Student > Doctoral Student 2 5%
Librarian 1 2%
Student > Bachelor 1 2%
Other 5 12%
Unknown 18 44%
Readers by discipline Count As %
Unspecified 11 27%
Medicine and Dentistry 8 20%
Nursing and Health Professions 2 5%
Biochemistry, Genetics and Molecular Biology 2 5%
Unknown 18 44%